rosuvastatin denk 20mg tablets film-coated
pharmaceutical works polpharma s.a. - rosuvastatin (rosuvastatin calcium) - tablets film-coated - 20mg
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
kaletra oral solution
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
rosuvastatin viatris 10 mg film-coated tablets
viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin
rosuvastatin viatris 20 mg film-coated tablets
viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin
rosuvastatin viatris 40 mg film-coated tablets
viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin
rosuvastatin viatris 5 mg film-coated tablets
viatris limited - rosuvastatin - film-coated tablet - hmg coa reductase inhibitors; rosuvastatin
ethinylestradiol/drospirenone leon farma & placebo 0.02 mg/3 mg film-coated tablets
laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.02/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol
ethinylestradiol/drospirenone leon farma & placebo 0.03 mg/3 mg film-coated tablets
laboratorios leon farma, s.a. - ethinylestradiol; drospirenone - film-coated tablet - 0.03/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol
hospira vincristine sulfate injection usp 2 mg/2 ml vial
hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; mannitol; sodium hydroxide; sulfuric acid - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, and wilm's tumor.